From 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk](1,4)benzodiazepin-2(1H)-one (TIBO) to etravirine (TMC125):: Fifteen years of research on non-nucleoside inhibitors of HIV-1 reverse transcriptase

被引：89

作者：

De Corte, BL ^{[1
]}

机构：

[1] Johnson & Johnson Pharmaceut Res & Dev, Drug Discovery, Spring House, PA 19477 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2005年 / 48卷 / 06期

关键词：

D O I：

10.1021/jm040127p

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：1689 / 1696

页数：8

共 58 条

[41] New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections [J].

Pauwels, R .

CURRENT OPINION IN PHARMACOLOGY, 2004, 4 (05) :437-446

[42] NEW TETRAHYDROIMIDAZO[4,5,1-JK][1,4]-BENZODIAZEPIN-2(1H)-ONE AND TETRAHYDROIMIDAZO[4,5,1-JK][1,4]-BENZODIAZEPIN-2(1H)-THIONE DERIVATIVES ARE POTENT INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION AND ARE SYNERGISTIC WITH 2',3'-DIDEOXYNUCLEOSIDE ANALOGS [J].

PAUWELS, R ;

ANDRIES, K ;

DEBYSER, Z ;

KUKLA, MJ ;

SCHOLS, D ;

BRESLIN, HJ ;

WOESTENBORGHS, R ;

DESMYTER, J ;

JANSSEN, MAC ;

DE CLERCQ, E ;

JANSSEN, PAJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (12) :2863-2870

[43] POTENT AND HIGHLY SELECTIVE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INHIBITION BY A SERIES OF ALPHA-ANILINOPHENYLACETAMIDE DERIVATIVES TARGETED AT HIV-1 REVERSE-TRANSCRIPTASE [J].

PAUWELS, R ;

ANDRIES, K ;

DEBYSER, Z ;

VAN DAELE, P ;

SCHOLS, D ;

STOFFELS, P ;

DEVREESE, K ;

WOESTENBORGHS, R ;

VANDAMME, AM ;

JANSSEN, CGM ;

ANNE, J ;

CAUWENBERGH, G ;

DESMYTER, J ;

HEYKANTS, J ;

JANSSEN, MAC ;

DE CLERCQ, E ;

JANSSEN, PAJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) :1711-1715

[44] POTENT AND SELECTIVE-INHIBITION OF HIV-1 REPLICATION INVITRO BY A NOVEL SERIES OF TIBO DERIVATIVES [J].

PAUWELS, R ;

ANDRIES, K ;

DESMYTER, J ;

SCHOLS, D ;

KUKLA, MJ ;

BRESLIN, HJ ;

RAEYMAECKERS, A ;

VANGELDER, J ;

WOESTENBORGHS, R ;

HEYKANTS, J ;

SCHELLEKENS, K ;

JANSSEN, MAC ;

DECLERCQ, E ;

JANSSEN, PAJ .

NATURE, 1990, 343 (6257) :470-474

[45] RAPID AND AUTOMATED TETRAZOLIUM-BASED COLORIMETRIC ASSAY FOR THE DETECTION OF ANTI-HIV COMPOUNDS [J].

PAUWELS, R ;

BALZARINI, J ;

BABA, M ;

SNOECK, R ;

SCHOLS, D ;

HERDEWIJN, P ;

DESMYTER, J ;

DECLERCQ, E .

JOURNAL OF VIROLOGICAL METHODS, 1988, 20 (04) :309-321

[46] BIS(HETEROARYL)PIPERAZINE (BHAP) REVERSE-TRANSCRIPTASE INHIBITORS - STRUCTURE-ACTIVITY-RELATIONSHIPS OF NOVEL SUBSTITUTED INDOLE ANALOGS AND THE IDENTIFICATION OF 1-[(5-METHANESULFONAMIDO-1H-INDOL-2-YL)-CARBONYL]-4-[3-[(1-METHYLETHYL)AMINO]-PYRIDINYL]PIPERAZINE MONOMETHANESULFONATE (U-90152S), A 2ND-GENERATION CLINICAL CANDIDATE [J].

ROMERO, DL ;

MORGE, RA ;

GENIN, MJ ;

BILES, C ;

BUSSO, M ;

RESNICK, L ;

ALTHAUS, IW ;

REUSSER, F ;

THOMAS, RC ;

TARPLEY, WG .

JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (10) :1505-1508

[47]

Ruiz N., 2002, 9 C RETR OPP INF SEA

[48] Nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase [J].

Sharma, PL ;

Nurpeisov, V ;

Hernandez-Santiago, B ;

Beltran, T ;

Schinazi, RF .

CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (09) :895-919

[49] STRUCTURE OF THE BINDING-SITE FOR NONNUCLEOSIDE INHIBITORS OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].

SMERDON, SJ ;

JAGER, J ;

WANG, J ;

KOHLSTAEDT, LA ;

CHIRINO, AJ ;

FRIEDMAN, JM ;

RICE, PA ;

STEITZ, TA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :3911-3915

[50] Capravirine -: Anti-HIV agent -: Reverse transcriptase inhibitor [J].

Sorbera, LA ;

Castañer, J ;

Bayés, M .

DRUGS OF THE FUTURE, 2003, 28 (12) :1149-1158

← 1 2 3 4 5 6 →